2011
DOI: 10.3858/emm.2011.43.4.026
|View full text |Cite
|
Sign up to set email alerts
|

Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers

Abstract: Parkinson's disease (PD) is characterized by selective and progressive degeneration of dopamine (DA)-producing neurons in the substantia nigra pars compacta (SNpc) and by abnormal aggregation of α -synuclein. Previous studies have suggested that DA can interact with α -synuclein, thus modulating the aggregation process of this protein; this interaction may account for the selective vulnerability of DA neurons in patients with PD. However, the relationship between DA and α -synuclein, and the role in progressiv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
100
0
3

Year Published

2012
2012
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 123 publications
(112 citation statements)
references
References 30 publications
9
100
0
3
Order By: Relevance
“…Finally, α-syn oligomers were produced by coincubation of monomeric α-syn with excess dopamine. [29][30][31] Under these conditions,~50% of monomeric α-syn was converted to oligomers after 4 days, as assessed by size exclusion chromatography (SEC) (Figure 1h). The purity, heterogeneity and amyloidogenic properties of α-syn oligomers were assessed by SEC, SDS-PAGE electrophoresis, TEM and ThT binding assay (Figures 1h-k).…”
Section: Resultsmentioning
confidence: 99%
“…Finally, α-syn oligomers were produced by coincubation of monomeric α-syn with excess dopamine. [29][30][31] Under these conditions,~50% of monomeric α-syn was converted to oligomers after 4 days, as assessed by size exclusion chromatography (SEC) (Figure 1h). The purity, heterogeneity and amyloidogenic properties of α-syn oligomers were assessed by SEC, SDS-PAGE electrophoresis, TEM and ThT binding assay (Figures 1h-k).…”
Section: Resultsmentioning
confidence: 99%
“…In the presence of dopamine, recombinant human ␣-synuclein produces nonfibrillar, SDSresistant oligomers, whereas ␤-sheet-rich fibril formation is inhibited. Pharmacologic elevation of the cytoplasmic dopamine level increased the formation of SDS-resistant oligomers in DA-producing neuronal cells (49). Thus, in this case, neurotransmitter signaling appears to regulate peptide oligomerization and secretion of ␣-synuclein oligomers.…”
Section: Discussionmentioning
confidence: 90%
“…It has been reported that dopamine accelerates the α-synuclein oligomerization in intracellular vesicles and promotes the production of extracellular α-synuclein [46], which may contribute to the progressive loss of the dopaminergic neuronal population in the SNpc in the PD patients.…”
Section: The Extracellular α-Synuclein and Parkinson's Diseasementioning
confidence: 99%